Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis.
Whittle SL, Glennon V, Johnston RV, Avery JC, Bell JS, Brennan SE, Fong C, Hissaria P, Horgan B, O'Neill S, Pisaniello HL, Trevena L, Whittaker GA, Wluka A, Buchbinder R.
Whittle SL, et al. Among authors: buchbinder r.
Intern Med J. 2022 Oct;52(10):1799-1805. doi: 10.1111/imj.15816.
Intern Med J. 2022.
PMID: 35567366